Hospitals

Nusano Named “Researcher of the Year” at Inaugural Best of BioHive Awards

WEST VALLEY CITY, Utah, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Nusano, a physics company committed to bringing supply stability and…

10 months ago

AMN Healthcare Announces Fourth Quarter and Full Year 2024 Results

Quarterly revenue of $735 million;GAAP loss of ($4.90)/share and adjusted EPS of $0.75 DALLAS, Feb. 20, 2025 (GLOBE NEWSWIRE) --…

10 months ago

Waystar Announces Pricing of Public Offering of Common Stock

LEHI, UT. and LOUISVILLE, KY., Feb. 20, 2025 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY) ("Waystar"), a provider of leading healthcare…

10 months ago

NAVER D2SF-Backed PranaQ® Receives FDA 510(k) Clearance for TipTraQ, an AI-Enabled Home Sleep Apnea Test

SEOUL, South Korea, Feb. 20, 2025 /PRNewswire/ -- PranaQ, backed by NAVER D2SF continues to push the boundaries of AI-powered…

10 months ago

QuicksortRx Wins Best in KLAS for Purchasing Optimization Analytics

CHARLESTON, S.C., Feb. 20, 2025 /PRNewswire/ -- QuicksortRx, a technology company helping health systems reduce medication costs and improve pharmacy…

10 months ago

Ginkgo Bioworks Partners with HaDEA in Up to €24 Million Consortium Project to Deliver Next-Generation ‘Agnostic Diagnostics’ for Respiratory Viruses at the Point of Care

International consortium to develop rapid metagenomic NGS solutions that can identify known and novel respiratory pathogens, reduce time-to-diagnosis, and enhance…

10 months ago

GlobalMed and ADS Collaborate to Enhance Access to Care and Operational Efficiency

SCOTTSDALE, Ariz., Feb. 20, 2025 /PRNewswire/ -- GlobalMed, a global leader in digital health solutions, is proud to announce a…

10 months ago

Bonus Biogroup Announces U.S. Food and Drug Administration (FDA) Clearance of an Investigational New Drug (IND) Application for MesenCure™ Phase III Clinical Study in Respiratory Distress

The Company is working to expand its indication to include patients who have respiratory distress from any cause, including acute…

10 months ago

TMDX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that TransMedics Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of TransMedics Group,…

10 months ago

Consumers Concerned About their Healthcare Data Being Compromised as Hospitals Balance Innovation with the Fundamentals

Report on clinical data reveals a challenging environment for hospitals and health systems alongside growing concerns from patients about their…

10 months ago